rxstat › Classes › Anterior Pituitary Lobe Hormones And Analogues

Anterior Pituitary Lobe Hormones And Analogues: shortage status in Canada

1 of the 5 anterior pituitary lobe hormones and analogues rxstat tracks is currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.

Tetracosactide (Synacthen Depot) Partial shortage 1 of 2 reported products affected Somatropin (Genotropin) Shortage anticipated 0 of 27 reported products affected Chloride Somatropin (Saizen) Discontinued 0 of 1 reported products affected Somatropin Diluent (Humatrope) Discontinued 0 of 3 reported products affected Tesamorelin (Egrifta) Discontinued 0 of 1 reported products affected

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.